# Male_Breast_Cancer-predictor


A machine-learning based model to predict and stratify the overall survival of male patients with hormone receptor (HR) positive, human epidermal growth factor receptor 2 (HER-2) negative early breast cancer. The model has not been peer-reviewed yet.

Copyright [2024] [YX-Gao953]

This code is publicly viewable but cannot be copied, modified, or distributed for commercial or non-commercial purposes without explicit permission from the copyright holder.
